American-origin check

Is Johnson & Johnson an American company?

Yes — Johnson & Johnson is an American company.

Johnson & Johnson is incorporated in New Jersey, United States and headquartered in New Brunswick, New Jersey. Its legal-entity record reports no foreign parent — the company is independently American-owned.

The evidence

Legal name: JOHNSON & JOHNSON
Incorporated in: New Jersey, United States
Registered office: New Brunswick, the United States
Headquarters: New Brunswick, New Jersey, United States
Ultimate owner: None reported (independent)
Stock listing: NYSE: JNJ on NYSE
LEI: 549300G0CFPGEF6X2043
Founded: 1886

Source: GLEIF, the global Legal Entity Identifier registry · checked Jul 26, 2026. A US headquarters or stock listing does not always mean US incorporation — this page reports what the legal-entity registry actually records.

Analysis

## The Short Answer Yes. [Johnson & Johnson](/company/johnson-johnson/) is an American company, founded in the United States in 1886 and headquartered in New Brunswick, New Jersey, where it remains based today. It trades publicly on the New York Stock Exchange under the ticker JNJ, and it appears in the americancompanies.com directory of US-based companies. ## A Company Rooted in New Jersey Johnson & Johnson's headquarters sit in New Brunswick, New Jersey, the same state where the company was founded in 1886. That founding date makes it one of the older continuously operating businesses in American pharmaceuticals, predating most of the modern drug industry by decades. ### On the New York Stock Exchange The company went public in September 1944, and shares have traded on the NYSE ever since under the symbol JNJ. A US stock exchange listing doesn't by itself define nationality, but combined with an American headquarters and founding, it reinforces the picture of a firm built and governed from inside the United States. ## What the Company Actually Does Johnson & Johnson describes itself as the world's largest and most diverse healthcare firm. It operates through two divisions — innovative medicine and medtech — which together represent all of the company's sales following the 2023 divestment of its former consumer business, Kenvue. ### A Sharper Drug Focus After restructuring in 2023-24, the innovative medicine division narrowed its focus to three main therapeutic areas: immunology, oncology, and neurology. That consolidation followed the separation of the consumer products business, leaving pharmaceuticals and medical technology as the company's two pillars. ## Scale of the Business The numbers behind Johnson & Johnson are substantial. For fiscal year 2025, the company reported revenue of $94.2 billion and net income of $26.8 billion, with total assets of $199.2 billion and a market capitalization of $560.3 billion. ### Where the Revenue Comes From Geographically, just over half of the company's total revenue is generated in the United States. That domestic majority, paired with the New Jersey headquarters and NYSE listing, is a meaningful marker of the company's American footprint even as it serves patients and healthcare systems around the world. ## The American Workforce Johnson & Johnson employs approximately 140,800 people across its operations. A workforce of that size, tied to a company headquartered and founded on US soil, underscores the scale of its presence within the American economy. ## Why the Distinction Matters For a curious reader, the question of nationality isn't just trivia — it shapes how a company is regulated, taxed, and counted in national economic statistics. By every verifiable marker available — founding year, headquarters location, stock exchange listing, and majority-domestic revenue — Johnson & Johnson checks the boxes of an American company, even as its healthcare business reaches patients across the globe. ![A researcher's gloved hands handling glass sample vials in a bright pharmaceutical laboratory setting.](/media/news/gen/is-johnson-johnson-an-american-company-heres-the-record-inline.jpg)